Requires pharmacy benefit managers to pay pharmacies at least the national average drug acquisition cost or pharmacy acquisition cost, plus a.
The bill mandates that pharmacy benefit managers pay participating pharmacies at least the national average drug acquisition cost (NADAC) rate or the pharmacy acquisition cost rate, whichever is higher, plus a professional dispensing fee. This applies to generic, brand name, biologic products, and drugs produced through genetic technology or biopharmaceutical processes. The bill also requires a reasonable process for appealing, investigating, and resolving disputes regarding drug pricing.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.